Abstract #4778

Role of DWI in guiding MRI-TRUS fusion biopsy in patients with prostate cancer: a prospective cohort study

Chandan J Das¹, Rohit Kaushal², Sanjay Sharma¹, Rajeev Kumar³, P N Dogra³, and S DattaGupta⁴

¹Radiology, All India Institute of Medical Sciences, New Delhi, India, NewDelhi, India, ²Uology, All India Institute of Medical Sciences, New Delhi, India, NewDelhi, India, ³Urology, All India Institute of Medical Sciences, New Delhi, India, NewDelhi, India, ⁴Pathology, All India Institute of Medical Sciences, New Delhi, India, NewDelhi, India

Transrectal ultrasound (TRUS) guided 12 core biopsy of prostate has a sensitivity of 39-52%. We prospectively evaluated the role of DWI in guiding MRI-TRUS fusion biopsy. MRI was performed on a 3 Tesla system. PIRAD score was assigned and PIRAD 3-5 score were subjected to targeted fusion biopsy using the Artemis device along with standard 12 core biopsies. Targeted biopsy detected a higher number (93%) of clinically significant cancers and 71% cancers were upgraded to significant cancer on targeted biopsy. Fusion biopsies guided by DWI thus provide incremental information over standard TRUS biopsies in the diagnosis of significant prostate cancer.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.